Prediction of outcomes in patients with Ph+ chronic myeloid leukemia in chronic phase treated with nilotinib after imatinib resistance/intolerance

The purpose was to assess predictive factors for outcome in patients with chronic myeloid leukemia (CML) in chronic phase (CML-CP) treated with nilotinib after imatinib failure. Imatinib-resistant and -intolerant patients with CML-CP (n = 321) were treated with nilotinib 400 mg twice daily. Of 19 ba...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
Main Authors: Jabbour, Elias, le Coutre, Philipp D., Cortes, Jorge, Giles, Francis, Bhalla, Kapil N., Pinilla-Ibarz, Javier, Larson, Richard A., Gattermann, Norbert, Ottmann, Oliver G., Hochhaus, Andreas, Hughes, Timothy P., Saglio, Giuseppe, Radich, Jerald P., Kim, Dong-Wook, Martinelli, Giovanni, Reynolds, John, Woodman, Richard C., Baccarani, Michele, Kantarjian, Hagop M.
פורמט: Artigo
שפה:Inglês
יצא לאור: 2012
נושאים:
Article
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC4140185/
https://ncbi.nlm.nih.gov/pubmed/23174881
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/leu.2012.305
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים